Stay updated on Entinostat + Pembrolizumab in Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.

Latest updates to the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page
- Check7 days agoChange DetectedThe page now displays an updated revision label, 'Revision: v3.6.2', replacing the previous 'Revision: v3.6.0'. This indicates a routine platform version update without changes to study details or navigation.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now indicates the study is no longer looking for participants and adds several help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), along with a formatting adjustment to the Intervention/Treatment heading and an updated revision version.SummaryDifference0.4%

- Check28 days agoChange DetectedThe revision tag on the page was updated from v3.5.4 to v3.5.5. This represents a minor update to the ClinicalTrials.gov record without changes to core study information.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a new build of the study page. This is metadata/version-control related and does not alter the study details or content visible to users.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a software/version change rather than any content change to the clinical study information.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.5.2 replaces the previous v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Entinostat + Pembrolizumab in Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.